retatrutide glp-1 gip glucagon receptor agonist Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research retatrutide gip glp-1 glucagon receptor

Patterson JT, Ottaway N, Gelfanov VM et al (2011) A novel human-based receptor antagonist of sustained action reveals body weight control by endogenous GLP-1

Research suggests it may influence slow-wave (delta) sleep the deepest and most restorative stage of sleep which is critical for physical repair, cognitive recovery, and hormonal balance

van Dam, E

Initiation Of SEMGLEE Therapy Recommended Starting Dosage In Patients With Type 1 Diabetes The recommended starting dosage of SEMGLEE in patients with type 1 diabetes is approximately one-third of the total daily insulin requirements

Due to these characteristics, BPC-157 has been evaluated in terms of its potential to aid in: Gut lining and intestinal healing Repairs of tendon and ligament